Kato Y, Seishima R, Hattori K, Kato H, et al. Significance of homologous recombinant deficiency as a biomarker for drug sensitivity in colorectal cancer. Br J Cancer 2025 Feb 11. doi: 10.1038/s41416-025-02950.
PMID: 39934338